2024-11-20 17:24:50
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program
Corporate/ 2023-07-23
Everest Medicines Announces Up to HK$100...

SHANGHAI,Nov.8,2021-- Everest Medicines (HKEX 1952.HK,"Everest" or the "Company"),a biopharmaceutical company focused on...

Ascentage Pharma Announces Clinical Trial Agreement to Evaluate the Combination of Lisaftoclax (APG-2575) and the CDK4/6 Inhibitor IBRANCE® (Palbociclib) in Metastatic ER+/HER2- Breast Cancer
Corporate/ 2023-07-23
Ascentage Pharma Announces Clinical Tria...

SUZHOU,China,and ROCKVILLE,Md.,Nov. 8,2021-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in d...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release